The new guidelines aim to streamline India’s drug approvals, improve transparency, and align regulatory practices with global ...

July marks a transformative month in oncology with the FDA's groundbreaking approvals and updates, enhancing treatment ...

After a decade of development, a Kansas City-based pharmaceutical company is on the brink of submitting its ADHD medication ...

The Trump administration is now accepting applications for a pilot program to demo rebates for 340B drugs that drugmakers ...

AbbVie submitted a supplemental new drug application for Venclexta plus Calquence treatment in previously untreated chronic ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

AbbVie seeks FDA approval for a groundbreaking oral treatment combining venetoclax and acalabrutinib, promising a new era in ...

The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.

AbbVie is seeking a new way to fight chronic lymphocytic leukemia by combining its oncology drug Venclexta with another ...

Johnson & Johnson (NYSE:JNJ) is one of the best trade‑war resistant stocks to buy now. On July 21, 2025, J&J submitted a New ...

Shares of Zymeworks were higher after the Food and Drug Administration cleared the company's investigational new drug application for its treatment for liver cancer. The stock rose 8.5%, to $14.46, in ...

Each year, the FDA approves a wide range of medications that help shape the future of medicine in the U.S. These include ...